Morrison Scott W 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Sep 17, 2024
Insider Transaction Report
Form 4
Morrison Scott W
Director
Transactions
- Exercise/Conversion
Common Stock
2024-09-15+1,333→ 6,016 total - Exercise/Conversion
Restricted Stock Units
2024-09-15−1,333→ 1,334 total→ Common Stock (1,333 underlying)
Footnotes (2)
- [F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F2]The RSUs vest in three equal annual installments on September 15th of 2023, 2024, and 2025, subject to the Reporting Person's continuous service.